Business Wire

Patient Safety Movement Foundation to Co-Convene World Summit with the European Society of Anaesthesiology

Share

The Patient Safety Movement Foundation announced today that the European Society of Anaesthesiology (ESA) will co-convene the upcoming 6th Annual World Patient Safety, Science & Technology Summit, held for the first time in London, United Kingdom, on February 23 – 25, 2018.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171108006256/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Patient Safety Movement Foundation Founder, Joe Kiani, and European Society of Anaesthesiologists President, Dr. Zeev Goldik, partner to co-convene 2018 World Patient Safety, Science & Technology Summit (Photo: Business Wire)

The World Patient Safety Summit is an impactful meeting where experts, patient advocates, and leaders from across the health care industry come together to discuss challenges, innovative new programs and best practices to prevent hospital errors and act to increase patient safety. Last year, more than 3,500 hospitals from 43 countries across the globe made commitments to the Patient Safety Movement Foundation to save more than 69,519 lives.

“We are delighted to be co-convening our annual summit with the European Society of Anaesthesiology,” said Joe Kiani, Founder of the Patient Safety Movement Foundation. “Patient safety is a critical challenge across the globe that impacts millions. Working hand in hand with leading medical societies, like the ESA, allows us to bring our message and our actionable patient safety solutions to save more people around the world.”

The European Society of Anaesthesiology (ESA) is the leading European Organization for Anaesthesia, Critical Care, Pain and Perioperative Medicine. The mission of the ESA is to aim for the highest standards of practice and safety in anaesthesia, perioperative medicine, intensive care, emergency medicine and pain treatment through education, research and professional development throughout Europe. The 2010 ESA-EBA Helsinki Declaration on Patient Safety in Anaesthesiology* was written to respond to preventable perioperative patient harm in surgery. It has been widely recognized globally as a practical framework for improving perioperative patient safety and has been signed by all European National Anaesthesiologists Societies and many international societies.

“Anaesthesiology shares responsibility for quality and safety in Anaesthesia, Intensive Care, Emergency Medicine and Pain Medicine, including the whole perioperative process and also in many other situations inside and outside the hospital where patients are at their most vulnerable,” says ESA President, Dr. Zeev Goldik. “The quality of care of our patients can only be reinforced and improved by ESA and the Patient Safety Movement joining forces.”

The 6th Annual World Patient Safety, Science & Technology Summit is organized with the support of the United Kingdom’s Secretary of State for Health, the Rt. Hon. Jeremy Hunt MP. The 2018 Summit will bring international hospital leaders, medical and information technology companies, the patient advocacy community, public policy makers and government officials together to discuss solutions to the leading challenges that cause preventable patient deaths in hospitals across the world. The Summit will feature keynote addresses from leading political figures and patient safety experts, plenary sessions with healthcare luminaries, members of the press and patient advocates, as well as announcements from organizations who have made their own commitments to reach the Patient Safety Movement Foundation’s goal of ZERO preventable deaths by 2020.

* Helsinki Declaration on Patient Safety in Anaesthesiology
Mellin-Olsen, Jannicke; Staender, Sven; Whitaker, David K; Smith, Andrew F
European Journal of Anaesthesiology: - July 2010 - Volume 27 - Issue 7 - p 592–597
doi: 10.1097/EJA.0b013e32833b1adf
http://journals.lww.com/ejanaesthesiology/Fulltext/2010/07000/The_Helsinki_Declaration_on_Patient_Safety_in.3.aspx

About Patient Safety Movement Foundation:

More than 200,000 people die every year in U.S. hospitals and 3 million worldwide in ways that could have been prevented. The Patient Safety Movement Foundation was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare to reduce that number of preventable deaths to 0 by 2020 (0X2020). Improving patient safety will require a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payers. The Patient Safety Movement Foundation works with all stakeholders to address the problems with actionable solutions for patient safety. The Foundation also convenes the World Patient Safety, Science and Technology Summit. The Summit brings together some of the world’s best minds for thought-provoking discussions and new ideas to challenge the status quo. By presenting specific, high-impact solutions to meet patient safety challenges, called Actionable Patient Safety Solutions, encouraging medical technology companies to share the data their products are purchased for, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions, the Patient Safety Movement Foundation is working toward zero preventable deaths by 2020. Visit http://patientsafetymovement.org/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Patient Safety Movement Foundation
Tanya Lyon, +1 (949) 351-2858
tanya.lyon@patientsafetymovement.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Curatis discloses Corticorelin as active substance of C-PTBE-0123.5.2025 08:00:00 EEST | Press release

An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema in association with malignant tumors. In previous clinical studies, human corticorelin (C-PTBE-01), demonstrated significant benefits in the treatment of PTBE. “The prospect of developing a potential blockbuster drug with that can contribute significantly to the quality of life of many patients, combined with the potential of maintaining the efficacy of immunotherapies for these patients, is very motivating and exciting,” said Dr. Roland Rutschmann, Curatis CEO. Key statements Corticorelin (hCRH), a 41 amino acid endogenous polypeptide, has demonstrated the ability to positively impact the blood-brain barrier after a disruption due to the underlying malignant tumor. Curatis intends to develop corticorelin to treat PTBE in primary and metasta

Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 202523.5.2025 00:43:00 EEST | Press release

Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4 in Chicago. The presentations include the Phase 3 MANEUVER data for potentially best-in-class pimicotinib in the treatment of the rare tumor TGCT, as well as data from both company- and investigator-sponsored studies highlighting the company’s focus on advancing differentiated molecules to tackle some of the most challenging cancers. “The new clinical data we are presenting at ASCO showcase our dedication to advancing innovative therapies for a wide range of diseases—spanning from common cancers to rare non-malignant neoplasms,” said Victoria Zazulina, M.D., Head of Development Unit, Oncology, for the Healthcare business of Merck. “From encouraging early data for our lead antibody-drug conjugate, precemtabart tocentecan, in patients with advanced CRC, to new Phase

Cooperation between Topcon Positioning Systems and Amberg Technologies Ltd.22.5.2025 23:17:00 EEST | Press release

Topcon Positioning Systems and Amberg Technologies Ltd. have initiated a close collaboration to enable interoperability between Topcon’s sensor solutions and Amberg Technologies’ software and hardware platforms for rail and tunnel applications. This marks the first step towards offering fully integrated solutions to our shared customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522363239/en/ Luc Le Maire, Senior Vice President, Topcon (left) and Johannes Mueller, CEO, Amberg Technologies. About Topcon Positioning Systems Topcon Positioning Systems is an industry-leading designer, manufacturer and distributor of precision measurement and workflow solutions for the global construction, geospatial and agriculture markets. Topcon Positioning Systems is headquartered in Livermore, California, U.S. (topconpositioning.com, LinkedIn, X, Facebook, Instagram). Its European head office is in Zoetermeer, Netherlands. Topcon Cor

LBT Holdings Ltd. Acquires Gonet Bank & Trust Limited, Introducing Bank of Nassau to Uphold the Finest Traditions of Private Banking22.5.2025 19:29:00 EEST | Press release

LBT Holdings Ltd., in partnership with Gonet SA, is pleased to announce the successful acquisition of Gonet Bank & Trust Limited, a distinguished Bahamas-based private bank formerly owned by Gonet SA. The transaction, which has received full regulatory approval from the Swiss Financial Market Supervisory Authority (FINMA), the Central Bank of The Bahamas (CBOB), and The Securities Commission of The Bahamas (SCB), marks a significant milestone for both organizations. Effective immediately, LBT Holdings Ltd. assumes 100% ownership of Gonet Bank & Trust Limited. As part of this strategic transition, Gonet Bank & Trust Limited will be rebranded as Bank of Nassau 1982 Limited, reflecting its renewed vision and commitment to excellence in private banking and wealth management. This acquisition strengthens the position of all parties in the global financial services sector, enabling expanded service offerings while upholding the highest standards of client-centric banking. Bank of Nassau 1982

PPG highlights continued progress toward 2030 sustainability targets in latest report22.5.2025 16:31:00 EEST | Press release

PPG (NYSE:PPG) today announced continued progress against its near-term 2030 sustainability targets, including reducing greenhouse gas (GHG) emissions throughout its own operations and value chain, and continued improvement in sustainably advantaged product sales driven by customer demand. “Sustainability is core to our purpose and a key enabler of our enterprise growth strategy,” said Peter Votruba-Drzal, PPG vice president, global sustainability. “It is embedded in how we do business by supporting our customers’ success through sustainably advantaged solutions that deliver industry-leading products, improved performance and operational savings, resulting in reduced water, waste and energy use.” Key highlights in PPG’s 2024 Sustainability Report include: 41% of sales from sustainably advantaged products, such as the PPG ENVIRO-PRIME® EPIC200X solution, which enabled a customer’s facility to reduce CO2 emissions by 3,500 metric tons annually. Significant expansion in renewable energy e

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye